Surgical Innovations ( (GB:SUN) ) has provided an announcement.
Surgical Innovations Group plc has announced a delay in the publication of its full-year results for 2024, now expected in May 2025, due to the appointment of a new Chief Financial Officer, Brent Greetham, during the audit process. This delay is intended to ensure a smooth transition and may impact stakeholders’ expectations regarding the company’s financial performance and operational transparency.
More about Surgical Innovations
Surgical Innovations Group plc specializes in the design, manufacture, sale, and distribution of innovative medical products primarily for minimally invasive surgery. They offer a range of products including branded port access systems, surgical instruments, and retraction devices, which are sold in the UK and exported globally. Their products are known for the ‘resposable’ concept, combining reusable and disposable elements to provide cost-effective and environmentally friendly solutions. The company also collaborates with OEM partners and provides precision engineering solutions.
Average Trading Volume: 2,764,859
Technical Sentiment Signal: Buy
Current Market Cap: £5.13M
Learn more about SUN stock on TipRanks’ Stock Analysis page.